Maternal diabetes-induced neural tube defects (NTDs) are associated with increased programmed cell death (apoptosis) in the neuroepithelium, which is related to intracellular nitrosative stress. To alleviate nitrosative stress, diabetic pregnant mice were fed via gavage an inhibitor of nitric oxide (NO) synthase (NOS) 2, L-N6-(1-iminoethyl)-lysine (L-NIL; 80 mg/kg), once a day from embryonic (E) day 7.5 to 9.5 during early stages of neurulation. The treatment significantly reduced NTD rate in the embryos, compared with that in vehicle (normal saline)-treated diabetic group. In addition to alleviation of nitrosative stress, endoplasmic reticulum (ER) stress was also ameliorated, assessed by quantification of associated factors. Apoptosis was reduced, indicated by caspase 8 activation. These results show that nitrosative stress is important in diabetes-induced NTDs via exacerbating ER stress, leading to increased apoptosis. Oral treatment with NOS-2 inhibitor alleviates nitrosative and ER stress, decreases apoptosis, and reduces NTDs in the embryos, providing information for further interventional studies to reduce diabetes-associated birth defects.
ZhaoZReeceEA. Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions. J Soc Gynecol Investig. 2005;12(8):549–557.
2.
LoekenMR. Challenges in understanding diabetic embryopathy. Diabetes. 2008;57(12):3187–3188.
3.
ErikssonUJBorgLACederbergJ. Pathogenesis of diabetes-induced congenital malformations. Ups J Med Sci. 2000;105(2):53–84.
4.
CorreaAGilboaSMBesserLM. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199(3):237. e1–e9.
5.
MillsJL. Malformations in infants of diabetic mothers. Teratology. 1982;25(3):385–394.
6.
SadlerTW. Embryology of neural tube development. Am J Med Genet. 2005;135C(1):2–8.
7.
WallingfordJB. Neural tube closure and neural tube defects: studies in animal models reveal known knowns and known unknowns. Am J Med Genet. 2005;135C(1):59–68.
8.
ChappellJHJrWangXDLoekenMR. Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis. 2009;14(12):1472–1483.
9.
ZhaoZYangPEckertRLReeceEA. Caspase-8: a key role in the pathogenesis of diabetic embryopathy. Birth Defects Res B Dev Reprod Toxicol. 2009;86(1):72–77.
10.
GareskogMCederbergJErikssonUJWentzelP. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos. Reprod Toxicol. 2007;23(1):63–74.
11.
SugimuraYMuraseTOyamaK. Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes. Diabetologia. 2009;52(5):962–971.
12.
JawerbaumAHigaRWhiteV. Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis. Reproduction. 2005;130(5):695–703.
KleinertHSchwarzPMForstermannU. Regulation of the expression of inducible nitric oxide synthase. Biol Chem. 2003;384(10-11):1343–1364.
19.
JawerbaumASinnerDWhiteVPustovrhCCapobiancoEGonzalezE. Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy δ12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. Reproduction. 2002;124(5):625–631.
20.
KumarSDYongSKDheenSTBayBHTaySSW. Cardiac malformations are associated with altered expression of vascular endothelial growth factor and endothelial nitric oxide synthase genes in embryos of diabetic mice. Exp Biol Med. 2008;233(11):1421–1432.
21.
MaattanenPGehringKBergeronJJThomasDY. Protein quality control in the ER: the recognition of misfolded proteins. Semin Cell Dev Biol. 2010;21(5):500–511.
22.
HamptonRY. ER stress response: getting the UPR hand on misfolded proteins. Curr Biol. 2000;10(14):R518–R521.
23.
KimIXuWReedJC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2008;7(12):1013–1030.
24.
MalhotraJDKaufmanRJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol. 2007;18(6):716–731.
25.
WuytackFRaeymaekersLMissiaenL. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium. 2002;32(5-6):279–305.
26.
HsiehYHSuIJLeiHYLaiMDChangWWHuangW. Differential endoplasmic reticulum stress signaling pathways mediated by iNOS. Biochem Biophys Res Commun. 2007;359(3):643–648.
27.
ReeceEAWuYKZhaoZDhanasekaranD. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol. 2006;194(2):580–585.
28.
ReeceEAWuYK. Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant. Am J Obstet Gynecol. 1997;176(4):790–797; discussion797–798.
29.
CederbergJSimanCMErikssonUJ. Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res. 2001;49(6):755–762.
30.
VianaMAruomaOIHerreraEBonetB. Oxidative damage in pregnant diabetic rats and their embryos. Free Radic Biol Med. 2000;29(11):1115–1121.
31.
VillarJPurwarMMerialdiM. World health organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG. 2009;116(6):780–788.
32.
RobinsonIde SernaDGGutierrezASchadeDS. Vitamin E in humans: an explanation of clinical trial failure. Endocr Pract. 2006;12(5):576–582.
33.
PolyzosNPMauriDTsappiM. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv. 2007;62(3):202–206.
34.
MooreWMWebberRKJeromeGMTjoengFSMiskoTPCurrieMG. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem. 1994;37(23):3886–3888.
35.
JunodALambertAEOrciLPictetRGonetAERenoldAE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 1967;126(1):201–205.
36.
ZhaoZ. Cardiac malformations and alteration of TGFβ signaling system in diabetic embryopathy. Birth Defects Res B Dev Reprod Toxicol. 2010;89(2):97–105.
37.
YangPZhaoZReeceEA. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Am J Obstet Gynecol. 2008;198(1):130. e1–e7.
38.
CoppAJGreeneNDMurdochJN. The genetic basis of mammalian neurulation. Nat Rev Genet2003;4(10):784–793.
39.
FujimotoMShimizuNKuniiKMartynJAUekiKKanekiM. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes. 2005;54(5):1340–1348.
40.
Carvalho-FilhoMARopelleERPauliRJ. Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia. 2009;52(11):2425–2434.
41.
BurdakovDPetersenOHVerkhratskyA. Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium. 2005;38(3-4):303–310.
EuJPXuLStamlerJSMeissnerG. Regulation of ryanodine receptors by reactive nitrogen species. Biochem Pharmacol. 1999;57(10):1079–1084.
44.
AdachiTWeisbrodRMPimentelDR. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med. 2004;10(11):1200–1207.
45.
SekineYTakedaKIchijoH. The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases. Curr Mol Med. 2006;6(1):87–97.
46.
YangPZhaoZReeceEA. Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy. Biochem Biophys Res Commun. 2007;357(3):749–754.
47.
UedaSMasutaniHNakamuraHTanakaTUenoMYodoiJ. Redox control of cell death. Antioxid Redox Signal. 2002;4(3):405–414.
48.
BreckenridgeDGGermainMMathaiJPNguyenMShoreGC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene. 2003;22(53):8608–8618.
49.
RavenJFKoromilasAE. PERK and PKR: old kinases learn new tricks. Cell Cycle. 2008;7(9):1146–1150.
50.
YonedaTImaizumiKOonoK. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem. 2001;276(17):13935–13940.
51.
LeeQPJuchauMR. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine. Teratology. 1994;49(6):452–464.
52.
FantelAGNekahiNShepardTHCornelLMUnisASLemireRJ. The teratogenicity of N(omega)-nitro-L-ariginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, in rats. Reprod Toxicol. 1997;11(5):709–717.
GreggARSchauerAShiOLiuZLeeCGO'BrienWE. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol. 1998;275(6 pt 2):H2319–H2324.
55.
HeflerLAReyesCAO'BrienWEGreggAR. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod. 2001;64(2):666–673.
56.
LaubachVESheselyEGSmithiesOShermanPA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A. 1995;93(23):10688–10692.
57.
HuangZHuangPLPanahianNDalkaraTFishmanMCMoskowitzMA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265(5180):1883–1885.
FantelAGPersonRE. Further evidence for the role of free radicals in the limb teratogenicity of L-NAME. Teratology. 2002;66(1):24–32.
60.
FantelAGStampsLDTranTTMacklerBPersonRENekahiN. Role of free radicals in the limb teratogenicity of L-NAME (N(G)-nitro-(L)-arginine methyl ester): a new mechanistic model of vascular disruption. Teratology. 1999;60(3):151–160.
61.
BustamanteSAPangYRomeroS. Inducible nitric oxide synthase and the regulation of central vessel caliber in the fetal rat. Circulation. 1996;94(8):1948–1953.
